Macular degeneration trials in Netherlands

2 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 2/3Active, not recruiting
  A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  Where

  Nijmegen, Rotterdam

  Age

  60 years and over

  People

  274 worldwide

  Run by

  Janssen Research & Development, LLC

  See details and how to joinNCT06635148 · EU 2022-500747-21-00
• Phase 3Not yet taking people in Netherlands
  Vitrectomy, Subretinal Tissue Plasminogen Activator (TPA) and Intravitreal Gas for Submacular Haemorrhage Secondary to Exudative (Wet) Age-related Macular Degeneration (TIGER).

  Where

  Nijmegen, Rotterdam

  Age

  50 years to 120 years

  People

  210 worldwide

  Run by

  King's College Hospital NHS Trust

  See details and how to joinNCT04663750 · EU 2023-504751-28-00